BioNeutral Announces Caliber Sales Engineering as an Authorized Dealer

By Bioneutral Group Inc., PRNE
Wednesday, June 15, 2011

NEWARK, New Jersey, June 16, 2011 -

BioNeutral Group Inc., (OTCBB: BONU) today announced the
appointment of Caliber Sales Engineering Inc. as an authorized
dealer of its EPA approved Ygiene Hospital and Military Grade
sterilant.  BioNeutral Ygiene product is used to sterilize any
hard surface in only 20 minutes.  The product has demonstrated
utility and effectiveness in industrial, health care and military
settings,  at the onset, the distribution agreement will be
limited to sales opportunities within the United States.

Caliber Sales Engineering Inc. is celebrating its 25th
Anniversary representing many premier defense equipment
manufacturers in the military aviation, marine, and tactical
markets.  Caliber  has a proven track record  in
providing support for legacy systems from high profile companies
such as Northrop Grumman, Lockheed Martin, Raytheon, and other
major U.S. manufacturers.

For more information on Caliber go to: href="">

Ygiene formulations are non corrosive and can be used in close
proximity to electronics and high grade stainless steel components.

“We at Caliber are excited about this opportunity and look
forward to working with BioNeutral and in leveraging our
distribution platform to market the all new and very unique Ygiene
product platform,” stated Vivian Alvarez, Director of Operations at
Caliber Sales Engineering.

About BioNeutral Group, Inc.

Headquartered at the New Jersey Institute of Technology/EDC in
Newark, NJ, BioNeutral Group, Inc., is a specialty technology-based
life science company which has developed a technology platform that
neutralizes harmful environmental contaminants, toxins and
dangerous micro-organisms including bacteria, viruses, mold, fungi
and spores. BioNeutral’s products, Ygiene® and Ogiene®, kill germs
and clean surfaces with a dramatic increase in speed and power over
their rivals in the marketplace. BioNeutral’s proprietary platform
technology has been proven effective in surface, water and airborne
applications. Its antimicrobial line of products under the Ygiene®
brand have been approved by the EPA for sale in the United States,
has previously been approved for sale in Germany and is also
permitted for sale in the UK, France and Sweden. AutoNeutral is a
registered trademark of BioNeutral Group, Inc. For more information
on BioNeutral, including a listing of the Company’s products,
leadership and background, please visit href="">

Find us on Facebook: href="">

Follow us on Twitter: href="">

Forward-Looking Statements

This release contains certain
“forward-looking statements” relating to the business of the
Company and its subsidiary companies. These forward-looking
statements are often identified by the use of forward-looking
terminology such as “believes,” “expects” or similar expressions.
Such forward looking statements involve known and unknown risks and
uncertainties that may cause actual results to be materially
different from those described herein as anticipated, believed,
estimated or expected. Investors should not place undue reliance on
these forward-looking statements, which speak only as of the date
of this press release. The company’s actual results could differ
materially from those anticipated in these forward-looking
statements as a result of a variety of factors, including those
described in the Company’s filings with the Securities and Exchange
Commission. BioNeutral routinely tests its formulations against
those of its competitors. The results are published to let
shareholders know how the Company’s technology compares with known
formulations in the market place. Any product claim for
antimicrobial activity requires approval from the EPA or FDA,
depending upon where and how the formulations are used. The EPA has
approved and registered the Company’s data and findings specific to
Ygiene®-206. BioNeutral’s antimicrobial formulations will be
marketed under the brand name Ygiene® and will soon be available
for sale in the United States.

Investor Relations Contact: Jeff Ramson, ProActive Capital Resources Group, LLC, +1-212-792-4294, jramson at; or FOR THE COMPANY: Stephen J. Browand, BioNeutral Group, Inc., +1-973-286-2899, steve at

will not be displayed